Farms.com Home   Ag Industry News

Trade deal with Japan includes U.S. ag

Trade deal with Japan includes U.S. ag
Sep 05, 2025
By Diego Flammini
Assistant Editor, North American Content, Farms.com

Japan commits to increasing ag purchases by $8 billion

A recently implemented trade agreement between the U.S. and Japan includes good news for the American ag sector.

The United States-Japan Agreement includes a commitment from Japan to increase its purchases of American agricultural products.

“Specifically, the Government of Japan is working toward an expedited implementation of a 75 percent increase of United States rice procurements within the Minimum Access rice scheme and purchases of United States agricultural goods, including corn, soybeans, fertilizer, bioethanol (including for sustainable aviation fuel), as well as other United States products, in amounts totaling $8 billion per year,” a Sept. 4 White House press release says.

In 2024, the U.S. exported almost $12 billion of agricultural goods to Japan, making it the fifth-largest destination for U.S. farm products.

This trade deal and its implications for U.S. ag has received support from multiple parties.

Agriculture Secretary Brooke Rollins, for example, called the development a “huge win for America’s farmers & ranchers,” on her X account, adding she’ll be in Japan soon to build on this agreement.

The American Soybean Association (ASA) welcomes the stronger partnership with Japan.

U.S. farmers require market access, which this trade agreement provides, said Caleb Ragland, president of the ASA.

“Reliable agreements like this not only strengthen markets for U.S. soy and keep America’s farm families a priority, but also help our farmers remain competitive in the global marketplace,” he said in a Sept. 5 statement.

In addition, Japan agreed to a 15 percent tariff on car imports into the U.S., and to invest $550 billion in U.S. projects.

The U.S. and Japan agreed to the trade deal in July.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.